4//SEC Filing
ENZON PHARMACEUTICALS INC 4
Accession 0001144204-13-051642
$ENZNCIK 0000727510operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 6:12 PM ET
Size
7.3 KB
Accession
0001144204-13-051642
Insider Transaction Report
Form 4
LEBUHN ROBERT
Director
Transactions
- Sale
Common Stock
2013-09-17$1.74/sh−34,807$60,456→ 63,308 total - Sale
Common Stock
2013-09-19$1.69/sh−21,119$35,626→ 42,189 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.66 to $1.745, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000727510
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 6:12 PM ET
- Size
- 7.3 KB